Target intelligence / Profile preview

Complex III assembly factor LYRM7 (LYRM7)

Target
LYRM7
Molecular classification
Mitochondrial assembly factor, Mitochondrial matrix protein, Chaperone protein, Other (non-structural, non-enzymatic assembly factor)
01

Overview

Complex III assembly factor LYRM7 (LYRM7) is a small, nuclear-encoded mitochondrial matrix protein essential for assembly of the mitochondrial respiratory chain complex III (ubiquinol-cytochrome c reductase). It acts as a dedicated chaperone for the Rieske iron-sulfur (Fe-S) protein (UQCRFS1), stabilizing and assisting its maturation and insertion into complex III. LYRM7 binds the co-chaperone HSC20, facilitating iron-sulfur cluster transfer from the main scaffold protein ISCU to UQCRFS1. Loss-of-function mutations in LYRM7 disrupt complex III assembly, resulting in severe mitochondrial complex III deficiency, which clinically manifests as varied early-onset neurometabolic disorders and leukoencephalopathy[1][2][3][4]. To date, there are no known therapeutic drugs that target LYRM7 directly; its dysfunction is primarily characterized by the loss of respiratory chain activity, rather than as a direct drug target.

Other names
LYR motif containing 7LYR motif-containing protein 7C5orf31MZM1LFLJ20796MC3DN8Lyrm7 homolog
02

Biological functions

Mitochondrial complex III assemblyChaperoning and incorporation of the iron-sulfur cluster into the Rieske (Fe-S) protein (UQCRFS1)Stabilization and maturation of UQCRFS1Electron transport chain function
03

Disease associations

Mitochondrial complex III deficiencyMitochondrial encephalopathy (e.g. leukoencephalopathy, neurometabolic disease)Early-onset neurological disorders
04

Safety considerations

Null (not a drug target, but loss of function results in severe mitochondrial disease)
05

Biomarkers

Reduction of complex III activity in muscle biopsy or fibroblastsLoss of LYRM7 protein (by Western blot)Decreased UQCRFS1 or complex III holocomplex

Beyond the preview

Go deeper on Complex III assembly factor LYRM7 (LYRM7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Complex III assembly factor LYRM7 (LYRM7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call